Skip to main content
SpringerLink
Log in

Tuberculosis

  • Chapter
  • First Online:
Book cover Nutrition and Health in a Developing World

Part of the book series: Nutrition and Health ((NH))

  • 3173 Accesses

Abstract

While major success has been achieved in tuberculosis prevention and control in recent years, the disease continues to affect many millions worldwide. Overall, this chapter summarizes the fundamental principles and concepts related to tuberculosis, and outlines key barriers that must be overcome to further reduce the global burden. The chapter opens with the characterization of the global tuberculosis threat, from both current and historical perspectives. The next section describes the epidemiology and major risk factors associated with Mycobacterium tuberculosis transmission, establishment of infection, and progression to active clinical disease. Following this, tuberculosis pathogenesis, diagnosis, and treatment are described. Lastly, current tuberculosis control strategies, including vaccination, are reviewed. Themes that cross chapter sections include drug-resistant tuberculosis and tuberculosis within vulnerable populations including those with HIV coinfection, young children, and those affected by poverty and/or special socioeconomic circumstances.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Health Organization. Global tuberculosis report 2014. World Health Organization; 2014.

    Google Scholar 

  2. Tan de Bibiana J, Rossi C, Rivest P, Zwerling A, Thibert L, McIntosh F, et al. Tuberculosis and homelessness in Montreal: a retrospective cohort study. BMC Public Health. 2011;11:833.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Commission on Social Determinants of Health. Closing the gap in a generation: health equity through action on the social determinants of health. Final Report of the Commission on Social Determinants of Health. Geneva: World Health Organization; 2008.

    Google Scholar 

  4. Pawlowski A, Jansson M, Skold M, Rottenberg ME, Kallenius G. Tuberculosis and HIV co-infection. PLoS Pathog. 2012;8(2):e1002464.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Dye C, Scheele S, Dolin P, Pathania V, Raviglione RC, Project WHOGSM. Global burden of tuberculosis—estimated incidence, prevalence, and mortality by country. JAMA (J Am Med Assoc). 1999;282(7):677–86.

    Google Scholar 

  6. Salo WL, Aufderheide AC, Buikstra J, Holcomb TA. Identification of mycobacterium-tuberculosis dna in a pre-columbian peruvian mummy. Proc Natl Acad Sci USA. 1994;91(6):2091–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Nerlich AG, Haas CJ, Zink A, Sziemles U, Hagedorn HG. Molecular evidence for tuberculosis in an ancient Egyptian mummy. Lancet. 1997;350(9088):1404.

    Google Scholar 

  8. Marten B. A new theory of consumptions, more especially of a phthisis or consumption of the lungs. London: Printed for R. Knaplock; A. Bell; J. Hooke, and C. King; 1720.

    Google Scholar 

  9. Daniel TM. Captain of death: the story of tuberculosis. Rochester, NY: University of Rochester Press; 1999.

    Google Scholar 

  10. Rogers K. Bacterial diseases: leprosy and tuberculosis. In: Rogers K, editor. Infectious diseases (Health and Disease in Society). New York: Rosen Education Service; 2011. p. 35–44.

    Google Scholar 

  11. Cantwell MF, Snider DE, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United-States, 1985 through 1992. JAMA (J Am Med Assoc). 1994;272(7):535–9.

    Article  CAS  Google Scholar 

  12. Streicher EM, Muller B, Chihota V, Mlambo C, Tait M, Pillay M, et al. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Infect Genet Evol. 2012;12(4):686–94 (Epub 2011/08/16).

    Article  PubMed  Google Scholar 

  13. World Health Organization. Tuberculosis fact sheet. Geneva, Switzerland: World Health Organization; 2014.

    Google Scholar 

  14. Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;378(9785):57–72.

    Article  PubMed  Google Scholar 

  15. Dheda K, Gumbo T, Gandhi NR, Murray M, Theron G, Udwadia Z, et al. Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. Lancet Respir Med. 2014;2(4):321–38.

    Article  PubMed  Google Scholar 

  16. Glaziou P, Falzon D, Floyd K, Raviglione M. Global epidemiology of tuberculosis. Semin Respir Crit Care Med. 2013;34(1):3–16 (Epub 2013/03/06).

    Article  PubMed  Google Scholar 

  17. Drobniewski F, Balabanova Y, Ruddy M, Weldon L, Jeltkova K, Brown T, et al. Rifampin- and multidrug-resistant tuberculosis in russian civilians and prison inmates: dominance of the beijing strain family. Emerg Infect Dis. 2002;8(11):1320–6.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, et al. Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the global project on anti-tuberculosis drug resistance surveillance. Lancet. 2009;373(9678):1861–73.

    Article  PubMed  Google Scholar 

  19. Anderson SR, Maguire H, Carless J. Tuberculosis in London: a decade and a half of no decline. Thorax. 2007;62(2):162–7.

    Article  PubMed  Google Scholar 

  20. Cain KP, Benoit SR, Winston CA, Mac Kenzie WR. Tuberculosis among foreign-born persons in the United States. JAMA (J Am Med Assoc). 2008;300(4):405–12.

    Article  CAS  Google Scholar 

  21. de Bruyn G, Adams GJ, Teeter LD, Soini H, Musser JM, Graviss EA. The contribution of ethnicity to Mycobacterium tuberculosis strain clustering. Int J Tuberc Lung Dis. 2001;5(7):633–41.

    PubMed  Google Scholar 

  22. Baker M, Das D, Venugopal K, Howden-Chapman P. Tuberculosis associated with household crowding in a developed country. J Epidemiol Comm Health. 2008;62(8):715–21.

    Article  CAS  Google Scholar 

  23. Centers for Disease Control & Prevention. Trends in tuberculosis—United States, 2011. MMWR (Morb Mortal Wkly Rep). 2012;61(11):181–5.

    Google Scholar 

  24. Acevedo-Garcia D. Zip code-level risk factors for tuberculosis: neighborhood environment and residential segregation in New Jersey, 1985–1992. Am J Public Health. 2001;91(5):734–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Williams G, Applewhite J. Tuberculosis in the Negroes of Georgia: economic, racial and constitutional aspects. Am J Hyg. 1939;29:61–109.

    Google Scholar 

  26. Stout JE, Saharia KK, Nageswaran S, Ahmed A, Hamilton CD. Racial and ethnic disparities in pediatric tuberculosis in North Carolina. Arch Pediatr Adolesc Med. 2006;160(6):631–7.

    Article  PubMed  Google Scholar 

  27. AHRQ. National healthcare disparities report. Rockville, MD2010. Available from: http://www.ahrq.gov/research/findings/nhqrdr/nhdr10/Ackno.html.

  28. Cantwell MF, McKenna MT, McCray E, Onorato IM. Tuberculosis and race/ethnicity in the United States: impact of socioeconomic status. Am J Respir Crit Care Med. 1998;157(4 Pt 1):1016–20.

    Article  CAS  PubMed  Google Scholar 

  29. Serpa JA, Teeter LD, Musser JM, Graviss EA. Tuberculosis disparity between US-born blacks and whites, Houston, Texas, USA. Emerg Infect Dis. 2009;15(6):899–904.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Tollefson D, Bloss E, Fanning A, Redd JT, Barker K, McCray E. Burden of tuberculosis in indigenous peoples globally: a systematic review. Int J Tuberc Lung Dis (Official Journal of the International Union against Tuberculosis and Lung Disease). 2013;17(9):1139–50.

    Article  CAS  Google Scholar 

  31. Bloss E, Holtz TH, Jereb J, Redd JT, Podewils LJ, Cheek JE, et al. TB in Indigenous peoples in the US, 2003–2008; 2011.

    Google Scholar 

  32. Pontororing GJ, Kenangalem E, Lolong DB, Waramori G, Sandjaja Tjitra E, et al. The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study. BMC Infect Dis. 2010;10:9.

    Article  Google Scholar 

  33. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis (The Official Journal of the International Union against Tuberculosis and Lung Disease). 2004;8(5):636–47.

    CAS  Google Scholar 

  34. Marais BJ. Tuberculosis in children. J Paediatr Child Health. 2014;50(10):759–67.

    Article  PubMed  Google Scholar 

  35. Rieder H, Cauthen G, Kelly G, Bloch A, Snider DJ. Tuberculosis in the United States. JAMA (J Am Med Assoc). 1989;262(3):385–9.

    Article  CAS  Google Scholar 

  36. Horwitz O, Knudsen J. A follow-up study of tuberculosis incidence and general mortality in various occupational-social groups of the Danish population. Bull World Health Organ. 1961;24:793–805.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Oren E, Winston CA, Pratt R, Robison VA, Narita M. Epidemiology of urban tuberculosis in the United States, 2000–2007. Am J Public Health. 2011;101(7):1256–63.

    Article  PubMed  PubMed Central  Google Scholar 

  38. de Vries G, Aldridge RW, Cayla JA, Haas WH, Sandgren A, van Hest NA, et al. Epidemiology of tuberculosis in big cities of the European Union and European Economic Area countries. Eurosurveillance. 2014;19(9):22–9.

    Article  Google Scholar 

  39. Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis. JAMA (J Am Med Assoc). 1995;274(12):945–51.

    Article  CAS  Google Scholar 

  40. Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991;144(4):745–9.

    Article  CAS  PubMed  Google Scholar 

  41. Rose RC 3rd, McGowan JE Jr. Urban tuberculosis: some modern problems. Am J Med Sci. 1984;287(1):24–6.

    Article  PubMed  Google Scholar 

  42. Clark M, Riben P, Nowgesic E. The association of housing density, isolation and tuberculosis in Canadian First Nations communities. Int J Epidemiol. 2002;31(5):940–5.

    Article  PubMed  Google Scholar 

  43. Chen W, Shu W, Wang M, Hou Y, Xia Y, Xu W, et al. Pulmonary tuberculosis incidence and risk factors in rural areas of China: a cohort study. PLoS ONE. 2013;8(3):e58171.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Buu TN, van Soolingen D, Huyen MN, Lan NN, Quy HT, Tiemersma EW, et al. Tuberculosis acquired outside of households, rural Vietnam. Emerg Infect Dis. 2010;16(9):1466–8.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Van’t Hoog AH, Marston BJ, Ayisi JG, Agaya JA, Muhenje O, Odeny LO, et al. Risk factors for inadequate TB case finding in Rural Western Kenya: a comparison of actively and passively identified TB patients. PLoS ONE. 2013;8(4):e61162.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  46. Dowdy DW, Cattamanchi A, Steingart KR, Pai M. Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis. PLoS Med. 2011;8(7):e1001063 (Epub 2011/08/05).

    Google Scholar 

  47. Hargreaves S, Carballo M, Friedland JS. Screening migrants for tuberculosis: where next? Lancet Infect Dis. 2009;9(3):139–40.

    Article  PubMed  Google Scholar 

  48. Pottie K, Janakiram P, Topp P, McCarthy A. Prevalence of selected preventable and treatable diseases among government-assisted refugees: implications for primary care providers. Can Fam Physician (Medecin de famille canadien). 2007;53(11):1928–34.

    Google Scholar 

  49. Centers for Disease Control & Prevention. Trends in tuberculosis–United States, 2012. MMWR (Morb Mortal Wkly Rep). 2013;62(11):201–5.

    Google Scholar 

  50. Menzies HJ, Winston CA, Holtz TH, Cain KP, Mac Kenzie WR. Epidemiology of tuberculosis among US- and foreign-born children and adolescents in the United States, 1994–2007. Am J Public Health. 2010;100(9):1724–9.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Odone A, Ricco M, Morandi M, Borrini BM, Pasquarella C, Signorelli C. Epidemiology of tuberculosis in a low-incidence Italian region with high immigration rates: differences between not Italy-born and Italy-born TB cases. BMC Public Health. 2011;11:376.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Inigo J, Garcia de Viedma D, Arce A, Palenque E, Alonso Rodriguez N, Rodriguez E, et al. Analysis of changes in recent tuberculosis transmission patterns after a sharp increase in immigration. J Clin Microbiol. 2007;45(1):63–9.

    Article  PubMed  Google Scholar 

  53. World Health Organization. Tuberculosis control in prisons: a manual for programme managers. Geneva: WHO; 2000.

    Google Scholar 

  54. Kim S, Crittenden KS. Risk factors for tuberculosis among inmates: a retrospective analysis. Public Health Nurs. 2005;22(2):108–18.

    Article  PubMed  Google Scholar 

  55. MacNeil JR, Lobato MN, Moore M. An unanswered health disparity: tuberculosis among correctional inmates, 1993 through 2003. Am J Public Health. 2005;95(10):1800–5.

    Article  PubMed  PubMed Central  Google Scholar 

  56. White MC, Tulsky JP, Portillo CJ, Menendez E, Cruz E, Goldenson J. Tuberculosis prevalence in an urban jail: 1994 and 1998. Int J Tuberc Lung Dis (The Official Journal of the International Union against Tuberculosis and Lung Disease). 2001;5(5):400–4.

    CAS  Google Scholar 

  57. Cummings KC, Mohle-Boetani J, Royce SE, Chin DP. Movement of tuberculosis patients and the failure to complete antituberculosis treatment. Am J Respir Crit Care Med. 1998;157(4 Pt 1):1249–52 (Epub 1998/05/01).

    Article  CAS  PubMed  Google Scholar 

  58. Thiede H, Romero M, Bordelon K, Hagan H, Murrill CS. Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users. J Urban Health (Bulletin of the New York Academy of Medicine). 2001;78(2):264–78 (Epub 2001/06/23).

    CAS  PubMed Central  Google Scholar 

  59. Martin V, Gonzalez P, Cayla JA, Mirabent J, Canellas J, Pina JM, et al. Case-finding of pulmonary tuberculosis on admission to a penitentiary centre. Tubercle Lung Dis (The Official Journal of the International Union Against Tuberculosis and Lung Disease). 1994;75(1):49–53 (Epub 1994/02/01).

    Article  CAS  Google Scholar 

  60. Drobniewski FA, Balabanova YM, Ruddy MC, Graham C, Kuznetzov SI, Gusarova GI, et al. Tuberculosis, HIV seroprevalence and intravenous drug abuse in prisoners. Eur Resp J. 2005;26(2):298–304.

    Article  CAS  Google Scholar 

  61. Stuckler D, Basu S, McKee M, King L. Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. Proc Natl Acad Sci U S A. 2008;105(36):13280–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Shilova MV, Dye C. The resurgence of tuberculosis in Russia. Philos Trans R Soc Lond Ser B-Biol Sci. 2001;356(1411):1069–75.

    Article  CAS  Google Scholar 

  63. Perlman DC, Salomon N, Perkins MP, Yancovitz S, Paone D, Des Jarlais DC. Tuberculosis in drug users. Clin Infect Dis (An Official Publication of the Infectious Diseases Society of America). 1995;21(5):1253–64.

    Article  CAS  Google Scholar 

  64. Chin DP, Cummings KC, Sciortino S, Snyder DC, Johnson LF, Westenhouse JL, et al. Progress and problems in achieving the United States national target for completion of antituberculosis treatment. Int J Tuberc Lung Dis (The Official Journal of the International Union Against Tuberculosis and Lung Disease). 2000;4(8):744–51.

    CAS  Google Scholar 

  65. Oeltmann J, Kammerer J, Pevzner E, Moonan P. Tuberculosis and substance abuse in the United States, 1997–2006. Arch Intern Med. 2009;169(2):189–97.

    Article  PubMed  Google Scholar 

  66. Sterling TR. Report from the 38th IDSA: tuberculosis & HIV. Hopkins HIV Rep (A Bimonthly Newsletter for Healthcare Providers/Johns Hopkins University AIDS Service). 2000;12(5):2.

    Google Scholar 

  67. Malakmadze N, Gonzalez IM, Oemig T, Isiadinso I, Rembert D, McCauley MM, et al. Unsuspected recent transmission of tuberculosis among high-risk groups: implications of universal tuberculosis genotyping in its detection. Clin Infect Dis (An Official Publication of the Infectious Diseases Society of America). 2005;40(3):366–73.

    Article  Google Scholar 

  68. Macq J, Solis A, Martinez G, Martiny P, Dujardin B. An exploration of the social stigma of tuberculosis in five “municipios” of Nicaragua to reflect on local interventions. Health Policy. 2005;74(2):205–17 (Epub 2005/09/13).

    Article  PubMed  Google Scholar 

  69. Dodor EA, Neal K, Kelly S. An exploration of the causes of tuberculosis stigma in an urban district in Ghana. Int J Tuberc Lung Dis (The Official Journal of the International Union against Tuberculosis and Lung Disease). 2008;12(9):1048–54 (Epub 2008/08/21).

    CAS  Google Scholar 

  70. Sengupta S, Pungrassami P, Balthip Q, Strauss R, Kasetjaroen Y, Chongsuvivatwong V, et al. Social impact of tuberculosis in southern Thailand: views from patients, care providers and the community. Int J Tuberc Lung Dis (The Official Journal of the International Union against Tuberculosis and Lung Disease). 2006;10(9):1008–12 (Epub 2006/09/13).

    CAS  Google Scholar 

  71. Coreil J, Lauzardo M, Heurtelou M. Cultural feasibility assessment of tuberculosis prevention among persons of Haitian origin in South Florida. J Immigr Health. 2004;6(2):63–9 (Epub 2004/03/12).

    Article  PubMed  Google Scholar 

  72. Osei E, Akweongo P, Binka F. Factors associated with DELAY in diagnosis among tuberculosis patients in Hohoe Municipality,Ghana. BMC Public Health. 2015;15:721 (Epub 2015/07/30).

    Article  PubMed  PubMed Central  Google Scholar 

  73. Kipp AM, Pungrassami P, Stewart PW, Chongsuvivatwong V, Strauss RP, Van Rie A. Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales. Int J Tuberc Lung Dis (The Official Journal of the International Union against Tuberculosis and Lung Disease) 2011;15(11):1540–5, i (Epub 2011/10/20).

    Google Scholar 

  74. McShane H. Co-infection with HIV and TB: double trouble. Int J STD & AIDS. 2005;16(2):95–100; quiz 1 (Epub 2005/04/06).

    Google Scholar 

  75. Baussano I, Nunn P, Williams B, Pivetta E, Bugiani M, Scano F. Tuberculosis among health care workers. Emerg Infect Dis. 2011;17(3):488–94 (Epub 2011/03/12).

    Article  PubMed  PubMed Central  Google Scholar 

  76. Baker MA, Lin HH, Chang HY, Murray MB. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clin Infect Dis. 2012;54(6):818–25.

    Article  PubMed  Google Scholar 

  77. Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Dye C, et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health. 2007;7:8.

    Article  Google Scholar 

  78. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lonnroth K, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9:15.

    Article  Google Scholar 

  79. Bock NN, Jensen PA, Miller B, Nardell E. Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment. J Infect Dis. 2007;196(Suppl 1):S108–13 (Epub 2007/08/30).

    Article  PubMed  Google Scholar 

  80. Fennelly KP, Martyny JW, Fulton KE, Orme IM, Cave DM, Heifets LB. Cough-generated aerosols of Mycobacterium tuberculosis—a new method to study infectiousness. Am J Respir Crit Care Med. 2004;169(5):604–9.

    Article  PubMed  Google Scholar 

  81. Loudon RG, Spohn SK. Cough frequency and infectivity in patients with pulmonary tuberculosis. Am Rev Respir Dis. 1969;99(1):109.

    CAS  PubMed  Google Scholar 

  82. Jones-Lopez EC, Namugga O, Mumbowa F, Ssebidandi M, Mbabazi O, Moine S, et al. Cough aerosols of Mycobacterium tuberculosis predict new infection: a household contact study. Am J Respir Crit Care Med. 2013;187(9):1007–15 (Epub 2013/01/12).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Loudon RG, Roberts RM. Singing and dissemination of tuberculosis. Am Rev Respir Dis. 1968;98(2):297.

    CAS  PubMed  Google Scholar 

  84. Riley RL, Mills CC, Nyka W, Weinstock N, Storey PB, Sultan LU, et al. Aerial dissemination of pulmonary tuberculosis—a 2-year study of contagion in a tuberculosis ward (reprinted). Am J Epidemiol. 1995;142(1):3–14.

    CAS  PubMed  Google Scholar 

  85. Riley RL, Shivpuri DN, Wittstadt F, Ogrady F, Sultan LU, Mills CC. Infectiousness of air from a tuberculosis ward—ultraviolet irradiation of infected air—comparative infectiousness of different patients. Am Rev Respir Dis. 1962;85(4):511.

    CAS  PubMed  Google Scholar 

  86. Escombe AR, Moore DAJ, Gilman RH, Navincopa M, Ticona E, Mitchell B, et al. Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission. PLoS Med. 2009;6(3):12.

    Article  Google Scholar 

  87. Nolan CM, Blumberg HM, Taylor Z, Bernardo J, Brennan PJ, Dunlap NE, et al. American thoracic society/centers for disease control and prevention/infectious diseases society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med. 2005;172(9):1169–227.

    Article  Google Scholar 

  88. Weir MR, Thornton GF. Extrapulmonary tuberculosis—experience of a community-hospital and review of the literature. Am J Med. 1985;79(4):467–78.

    Article  CAS  PubMed  Google Scholar 

  89. Comstock GW. Frost revisited—modern epidemiology of tuberculosis. Am J Epidemiol. 1975;101(5):363–82.

    Article  CAS  PubMed  Google Scholar 

  90. Lauzardo M, Lee P, Duncan H, Hale Y. Transmission of Mycobacterium tuberculosis to a funeral director during routine embalming. Chest. 2001;119(2):640–2 (Epub 2001/02/15).

    Article  CAS  PubMed  Google Scholar 

  91. Lauzardo M, Rubin J. Mycobacterial disinfection. In: Block SS, editor. Disinfection, sterilization, and preservation. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. p. 513–28.

    Google Scholar 

  92. Espiritu N, Aguirre L, Jave O, Sanchez L, Kirwan DE, Gilman RH. Congenital transmission of multidrug-resistant tuberculosis. Am J Trop Med Hyg. 2014;91(1):92–5 (Epub 2014/05/14).

    Article  PubMed  PubMed Central  Google Scholar 

  93. Lee LH, LeVea CM, Graman PS. Congenital tuberculosis in a neonatal intensive care unit: case report, epidemiological investigation, and management of exposures. Clin Infect Dis (An Official Publication of the Infectious Diseases Society of America). 1998;27(3):474–7 (Epub 1998/10/14).

    Article  CAS  Google Scholar 

  94. Perez-Lago L, Navarro Y, Garcia-de-Viedma D. Current knowledge and pending challenges in zoonosis caused by Mycobacterium bovis: a review. Res Vet Sci. 2013;97:S94–100.

    Google Scholar 

  95. Torres-Gonzalez P, Soberanis-Ramos O, Martinez-Gamboa A, Chavez-Mazari B, Barrios-Herrera MT, Torres-Rojas M, et al. Prevalence of latent and active tuberculosis among dairy farm workers exposed to cattle infected by Mycobacterium bovis. PLoS Neglected Trop Dis. 2013;7(4):e2177.

    Article  Google Scholar 

  96. Lienhardt C. From exposure to disease: the role of environmental factors in susceptibility to and development of tuberculosis. Epidemiol Rev. 2001;23(2):288–301.

    Article  CAS  PubMed  Google Scholar 

  97. Lygizos M, Shenoi SV, Brooks RP, Bhushan A, Brust JC, Zelterman D, et al. Natural ventilation reduces high TB transmission risk in traditional homes in rural KwaZulu-Natal, South Africa. BMC Infect Dis. 2013;13:300.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Drucker E, Alcabes P, Bosworth W, Sckell B. Childhood tuberculosis in the Bronx, New York. Lancet. 1994;343(8911):1482–5.

    Article  CAS  PubMed  Google Scholar 

  99. Lienhardt C, Fielding K, Sillah J, Tunkara A, Donkor S, Manneh K, et al. Risk factors for tuberculosis infection in sub-Saharan Africa: a contact study in The Gambia. Am J Respir Crit Care Med. 2003;168(4):448–55.

    Article  PubMed  Google Scholar 

  100. Dooley SW Jr, Castro KG, Hutton MD, Mullan RJ, Polder JA, Snider DE Jr. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR Recommendations Rep (Morbidity and Mortality Weekly Report Recommendations and Reports/Centers for Disease Control). 1990;39(Rr-17):1–29 (Epub 1990/12/07).

    Google Scholar 

  101. Feja K, Saiman L. Tuberculosis in children. Clin Chest Med. 2005;26(2):295–312, vii.

    Google Scholar 

  102. Jones-Lopez EC, Kim S, Fregona G, Marques-Rodrigues P, Hadad DJ, Molina LPD, et al. Importance of cough and M. tuberculosis strain type as risks for increased transmission within households. PLoS ONE. 2014;9(7):12.

    Article  CAS  Google Scholar 

  103. Kamat SR, Dawson JJ, Devadatta S, Fox W, Janardhanam B, Radhakrishna S, et al. A controlled study of the influence of segregation of tuberculous patients for one year on the attack rate of tuberculosis in a 5-year period in close family contacts in South India. Bull World Health Organ. 1966;34(4):517–32 (Epub 1966/01/01).

    CAS  PubMed  PubMed Central  Google Scholar 

  104. Abuogi LL, Mwachari C, Leslie HH, Shade SB, Otieno J, Yienya N, et al. Impact of expanded antiretroviral use on incidence and prevalence of tuberculosis in children with HIV in Kenya. Int J Tuberc Lung Dis. 2013;17(10):1291–7.

    Article  CAS  PubMed  Google Scholar 

  105. Greenaway C, Sandoe A, Vissandjee B, Kitai I, Gruner D, Wobeser W, et al. Tuberculosis: evidence review for newly arriving immigrants and refugees. Can Med Assoc J. 2011;183(12):E939–51.

    Article  Google Scholar 

  106. Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009;68(12):2240–6.

    Article  PubMed  Google Scholar 

  107. Möller M, Hoal EG. Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis. 2010;90(2):71–83.

    Article  PubMed  CAS  Google Scholar 

  108. Bellamy R. Genetic susceptibility to tuberculosis in human populations. Thorax. 1998;53(7):588–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Pan H, Yan BS, Rojas M, Shebzukhov YV, Zhou H, Kobzik L, et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature. 2005;434(7034):767–72 (Epub 2005/04/09).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. Willis MD, Winston CA, Heilig CM, Cain KP, Walter ND, Mac Kenzie WR. Seasonality of tuberculosis in the United States, 1993–2008. Clin Infect Dis (An Official Publication of the Infectious Diseases Society of America). 2012;54(11):1553–60 (Epub 2012/04/05).

    Article  Google Scholar 

  111. Fares A. Seasonality of tuberculosis. J Global Infect Dis. 2011;3(1):46–55 (Epub 2011/05/17).

    Article  Google Scholar 

  112. Koh GC, Hawthorne G, Turner AM, Kunst H, Dedicoat M. Tuberculosis incidence correlates with sunshine: an ecological 28-year time series study. PLoS ONE. 2013;8(3):e57752 (Epub 2013/03/14).

    Google Scholar 

  113. de Jong BC, Antonio M, Gagneux S. Mycobacterium africanum—review of an important cause of human tuberculosis in West Africa. PLoS Neglected Trop Dis. 2010;4(9):e744.

    Article  Google Scholar 

  114. Hesseling AC, Cotton MF, Fordham von Reyn C, Graham SM, Gie RP, Hussey GD. Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants. Int J Tuberc Lung Dis (The Official Journal of the International Union against Tuberculosis and Lung Disease). 2008;12(12):1376–9.

    Google Scholar 

  115. Gagneux S. Host-pathogen coevolution in human tuberculosis. Philos Trans R Soc Lond B Biol Sci. 2012;367(1590):850–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Prodinger WM, Indra A, Koksalan OK, Kilicaslan Z, Richter E. Mycobacterium caprae infection in humans. Expert Rev Anti-Infect Ther. 2014;12(12):1501–13.

    Article  CAS  PubMed  Google Scholar 

  117. Panteix G, Gutierrez MC, Boschiroli ML, Rouviere M, Plaidy A, Pressac D, et al. Pulmonary tuberculosis due to Mycobacterium microti: a study of six recent cases in France. J Med Microbiol. 2010;59(Pt 8):984–9.

    Article  CAS  PubMed  Google Scholar 

  118. van Ingen J, Rahim Z, Mulder A, Boeree MJ, Simeone R, Brosch R, et al. Characterization of Mycobacterium orygis as M. tuberculosis complex subspecies. Emerg Infect Dis. 2012;18(4):653–5.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Ueyama M, Chikamatsu K, Aono A, Murase Y, Kuse N, Morimoto K, et al. Sub-speciation of Mycobacterium tuberculosis complex from tuberculosis patients in Japan. Tuberculosis (Edinb). 2014;94(1):15–9.

    Article  CAS  PubMed  Google Scholar 

  120. Kiers A, Klarenbeek A, Mendelts B, Van Soolingen D, Koeter G. Transmission of Mycobacterium pinnipedii to humans in a zoo with marine mammals. Int J Tuberc Lung Dis (The Official Journal of the International Union against Tuberculosis and Lung Dis). 2008;12(12):1469–73.

    CAS  Google Scholar 

  121. Gagneux S, Small PM. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis. 2007;7(5):328–37.

    Article  PubMed  Google Scholar 

  122. Click ES, Moonan PK, Winston CA, Cowan LS, Oeltmann JE. Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis. Clin Infect Dis (An Official Publication of the Infectious Diseases Society of America). 2012;54(2):211–9 (Epub 2011/12/27).

    Article  Google Scholar 

  123. Cowley D, Govender D, February B, Wolfe M, Steyn L, Evans J, et al. Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clin Infect Dis (An Official Publication of the Infectious Diseases Society of America). 2008;47(10):1252–9 (Epub 2008/10/07).

    Article  Google Scholar 

  124. Parwati I, Alisjahbana B, Apriani L, Soetikno RD, Ottenhoff TH, van der Zanden AG, et al. Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia. J Infect Dis. 2010;201(4):553–7 (Epub 2010/01/13).

    Article  PubMed  Google Scholar 

  125. Grode L, Seiler P, Baumann S, Hess J, Brinkmann V, Nasser Eddine A, et al. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. J Clin Investig. 2005;115(9):2472–9 (Epub 2005/08/20).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA (J Am Med Assoc). 1994;271(9):698–702 (Epub 1994/03/02).

    Article  CAS  Google Scholar 

  127. Cantrell SA, Pascopella L, Flood J, Crane CM, Kendall LV, Riley LW. Community-wide transmission of a strain of Mycobacterium tuberculosis that causes reduced lung pathology in mice. J Med Microbiol. 2008;57(Pt 1):21–7 (Epub 2007/12/11).

    Article  CAS  PubMed  Google Scholar 

  128. O’Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune response in tuberculosis. Annu Rev Immunol. 2013;31:475–527.

    Article  PubMed  CAS  Google Scholar 

  129. Pagan AJ, Ramakrishnan L. Immunity and immunopathology in the tuberculous granuloma. Cold Spring Harb Perspect Med. 2014.

    Google Scholar 

  130. Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJD. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS ONE. 2011;6(4):e17601.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  131. Naing C, Mak JW, Maung M, Wong SF, Kassim AI. Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis. Lung. 2013;191(1):27–34.

    Article  PubMed  Google Scholar 

  132. Kato-Maeda M, Nahid P. Mycobacterium tuberculosis lineage—what’s in your lungs? Clin Infect Dis (An Official Publication of the Infectious Diseases Society of America). 2012;54(2):220–4.

    Article  Google Scholar 

  133. World Health Organization. Treatment of tuberculosis: guidelines, 4th ed. 2010.

    Google Scholar 

  134. Durr S, Muller B, Alonso S, Hattendorf J, Laisse CJ, van Helden PD, et al. Differences in primary sites of infection between zoonotic and human tuberculosis: results from a worldwide systematic review. PLoS Neglected Trop Dis. 2013;7(8):e2399.

    Article  Google Scholar 

  135. Cohen T, van Helden PD, Wilson D, Colijn C, McLaughlin MM, Abubakar I, et al. Mixed-strain Mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control. Clin Microbiol Rev. 2012;25(4):708–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  136. Walker NF, Meintjes G, Wilkinson RJ. HIV-1 and the immune response to TB. Future Virol. 2013;8(1):57–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  137. Nguyen H, Pandolfini C, Chiodini P, Bonati M. Tuberculosis care for pregnant women: a systematic review. BMC Infect Dis. 2014;14(1):617.

    Article  PubMed  PubMed Central  Google Scholar 

  138. Loto OM, Awowole I. Tuberculosis in pregnancy: a review. J Pregnancy. 2012;2012:379271.

    Article  PubMed  Google Scholar 

  139. Mathad JS, Gupta A. Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. Clin Infect Dis (An Official Publication of the Infectious Diseases Society of America). 2012;55(11):1532–49.

    Article  Google Scholar 

  140. Marais BJ. Quantifying the tuberculosis disease burden in children. Lancet. 2014;383(9928):1530–1.

    Article  PubMed  Google Scholar 

  141. World Health Organization. The stop TB strategy: building on and enhancing DOTS to meet the TB-related millennium development goals. 2006.

    Google Scholar 

  142. Pasipanodya JG, Gumbo T. A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients. Clin Infect Dis. 2013;57(1):21–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  143. World Health Organization. Global tuberculosis report 2014. Geneva; 2014.

    Google Scholar 

  144. Prevention CfDCa. Mantoux tuberculin skin testing products. 2012 [cited 2014 11/19/2014]. Available from: http://www.cdc.gov/tb/education/Mantoux/default.htm.

  145. World Health Organization. Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries: policy statement. 2011.

    Google Scholar 

  146. Steffen RE, Caetano R, Pinto M, Chaves D, Ferrari R, Bastos M, et al. Cost-effectiveness of Quantiferon(R)-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil. PLoS ONE. 2013;8(4):e59546.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  147. World Health Organization. Xpert MTB/RIF implementation manual: technical and operational ‘how-to’; practical considerations. 2014.

    Google Scholar 

  148. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Policy update. 2013.

    Google Scholar 

  149. World Health Organization. TB diagnostics and laboratory strengthening. 2015. Available from: http://www.who.int/tb/laboratory/mtbrifrollout/en/.

  150. FIND. Price for Xpert® MTB/RIF and FIND country list. 2015. Available from: http://www.finddiagnostics.org/about/what_we_do/successes/find-negotiated-prices/xpert_mtb_rif.html.

  151. World Health Organization. Guidelines on the management of latent tuberculosis infection. 2015.

    Google Scholar 

  152. Nechaeva OB, Skachkova EI, Fomina NI. [Drug resistance of Mycobacterium tuberculosis in the Sverdlovsk Region]. Problemy tuberkuleza. 2002(9):8–11 (Epub 2003/01/15). Lekarstvennaia ustoichivost’ mikobakterii tuberkuleza v Sverdlovskoi oblasti.

    Google Scholar 

  153. Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax. 2006;61(2):158–63.

    Article  CAS  PubMed  Google Scholar 

  154. PablosMendez A, Knirsch CA, Barr RG, Lerner BH, Frieden TR. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med. 1997;102(2):164–70.

    Article  CAS  Google Scholar 

  155. Pooran A, Pieterson E, Davids M, Theron G, Dheda K. What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa? PloS ONE. 2013;8(1):e54587 (Epub 2013/01/26).

    Google Scholar 

  156. World Health Organization. WHO policy on collaborative TB/HIV activities guidelines for national programmes and other stakeholders. 2012.

    Google Scholar 

  157. World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. 2015.

    Google Scholar 

  158. World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. 2011.

    Google Scholar 

  159. World Health Organization. BCG vaccine WHO position paper. Wkly Epidemiol Rec. 2004;4:27–38.

    Google Scholar 

  160. Hesseling AC, Schaaf HS, Victor T, Beyers N, Marais BJ, Cotton MF, et al. Resistant Mycobacterium bovis Bacillus Calmette-Guerin disease: implications for management of Bacillus Calmette-Guerin Disease in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23(5):476–9.

    Article  PubMed  Google Scholar 

  161. Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis (An Official Publication of the Infectious Diseases Society of America). 2014;58(4):470–80.

    Article  Google Scholar 

  162. Groschel MI, Prabowo SA, Cardona PJ, Stanford JL, van der Werf TS. Therapeutic vaccines for tuberculosis—a systematic review. Vaccine. 2014;32(26):3162–8.

    Article  PubMed  CAS  Google Scholar 

  163. Andersen P, Kaufmann SH. Novel vaccination strategies against tuberculosis. Cold Spring Harbor Perspect Med. 2014;4(6).

    Google Scholar 

  164. Poyntz HC, Stylianou E, Griffiths KL, Marsay L, Checkley AM, McShane H. Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. Tuberculosis (Edinb). 2014;94(3):226–37.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology and Biostatistics, Mel & Enid Zuckerman College of Public Health, University of Arizona, 1295 N. Martin Ave., PO Box 245211, Tucson, AZ, 85724, USA

    Eyal Oren

  2. Department of Medicine, Division of Infectious Diseases and International Health, School of Medicine, University of Virginia, PO Box 801340, Charlottesville, VA, 22908, USA

    Joann M. McDermid

Authors
  1. Eyal Oren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joann M. McDermid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eyal Oren .

Editor information

Editors and Affiliations

  1. World Food Programme , Rome, Italy

    Saskia de Pee

  2. School of Public Health, University of Arizona Mel and Enid Zuckerman, Tucson, Arizona, USA

    Douglas Taren

  3. World Food Programme, Nutrition Division , Rome, Italy

    Martin W. Bloem

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media New York

About this chapter

Cite this chapter

Oren, E., McDermid, J.M. (2017). Tuberculosis. In: de Pee, S., Taren, D., Bloem, M. (eds) Nutrition and Health in a Developing World . Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-43739-2_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43739-2_17

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-43737-8

  • Online ISBN: 978-3-319-43739-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation